Surgical Treatment for Renal Cell Carcinoma View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2017-02-16

AUTHORS

Dae Y. Kim , Jose A. Karam , Christopher G. Wood

ABSTRACT

Systemic therapies for renal cell carcinoma have made modest improvements in patient survival but rarely offer durable cure. Thus, surgical excision of renal cell carcinoma is an integral component of oncologic management. The spectrum of renal cell carcinoma presentation from small renal masses, locally advanced disease, and in the presence of metastasis varies with the surgical armamentarium needed to treat this diverse group of patients. In general for small renal masses, a nephron-sparing approach is preferred if it can be completed safely with negative margins, and for locally advanced tumors, radical nephrectomy is preferred with excision of the affected kidney, lymph nodes, and venous thrombi if present. With metastatic disease, cytoreductive nephrectomy has been shown to prolong survival in carefully selected patients, usually with good performance status and with oligometastasis. The surgical nuances, indication, and motivation for each surgical technique will be discussed in this chapter. More... »

PAGES

221-235

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-4-431-55531-5_8

DOI

http://dx.doi.org/10.1007/978-4-431-55531-5_8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1083892464


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Urology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Dae Y.", 
        "id": "sg:person.01264361105.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264361105.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karam", 
        "givenName": "Jose A.", 
        "id": "sg:person.01246663563.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246663563.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wood", 
        "givenName": "Christopher G.", 
        "id": "sg:person.01040121722.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2017-02-16", 
    "datePublishedReg": "2017-02-16", 
    "description": "Systemic therapies for renal cell carcinoma have made modest improvements in patient survival but rarely offer durable cure. Thus, surgical excision of renal cell carcinoma is an integral component of oncologic management. The spectrum of renal cell carcinoma presentation from small renal masses, locally advanced disease, and in the presence of metastasis varies with the surgical armamentarium needed to treat this diverse group of patients. In general for small renal masses, a nephron-sparing approach is preferred if it can be completed safely with negative margins, and for locally advanced tumors, radical nephrectomy is preferred with excision of the affected kidney, lymph nodes, and venous thrombi if present. With metastatic disease, cytoreductive nephrectomy has been shown to prolong survival in carefully selected patients, usually with good performance status and with oligometastasis. The surgical nuances, indication, and motivation for each surgical technique will be discussed in this chapter.", 
    "editor": [
      {
        "familyName": "Oya", 
        "givenName": "Mototsugu", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-4-431-55531-5_8", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-4-431-55530-8", 
        "978-4-431-55531-5"
      ], 
      "name": "Renal Cell Carcinoma", 
      "type": "Book"
    }, 
    "keywords": [
      "renal cell carcinoma", 
      "small renal masses", 
      "cell carcinoma", 
      "renal masses", 
      "good performance status", 
      "presence of metastases", 
      "nephron-sparing approach", 
      "cytoreductive nephrectomy", 
      "advanced disease", 
      "systemic therapy", 
      "durable cure", 
      "metastatic disease", 
      "performance status", 
      "lymph nodes", 
      "prolong survival", 
      "surgical treatment", 
      "surgical excision", 
      "oncologic management", 
      "radical nephrectomy", 
      "patient survival", 
      "negative margins", 
      "advanced tumors", 
      "venous thrombi", 
      "surgical technique", 
      "surgical nuances", 
      "surgical armamentarium", 
      "carcinoma", 
      "nephrectomy", 
      "modest improvement", 
      "patients", 
      "excision", 
      "disease", 
      "survival", 
      "oligometastasis", 
      "thrombus", 
      "metastasis", 
      "therapy", 
      "tumors", 
      "armamentarium", 
      "kidney", 
      "integral component", 
      "cure", 
      "treatment", 
      "presentation", 
      "diverse group", 
      "indications", 
      "status", 
      "group", 
      "mass", 
      "management", 
      "improvement", 
      "presence", 
      "margin", 
      "nodes", 
      "present", 
      "components", 
      "technique", 
      "nuances", 
      "approach", 
      "chapter", 
      "motivation", 
      "spectra"
    ], 
    "name": "Surgical Treatment for Renal Cell Carcinoma", 
    "pagination": "221-235", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1083892464"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-4-431-55531-5_8"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-4-431-55531-5_8", 
      "https://app.dimensions.ai/details/publication/pub.1083892464"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-10-01T06:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/chapter/chapter_406.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-4-431-55531-5_8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-4-431-55531-5_8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-4-431-55531-5_8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-4-431-55531-5_8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-4-431-55531-5_8'


 

This table displays all metadata directly associated to this object as RDF triples.

135 TRIPLES      22 PREDICATES      85 URIs      78 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-4-431-55531-5_8 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N60614f787a5748aabb23c18a85871aad
4 schema:datePublished 2017-02-16
5 schema:datePublishedReg 2017-02-16
6 schema:description Systemic therapies for renal cell carcinoma have made modest improvements in patient survival but rarely offer durable cure. Thus, surgical excision of renal cell carcinoma is an integral component of oncologic management. The spectrum of renal cell carcinoma presentation from small renal masses, locally advanced disease, and in the presence of metastasis varies with the surgical armamentarium needed to treat this diverse group of patients. In general for small renal masses, a nephron-sparing approach is preferred if it can be completed safely with negative margins, and for locally advanced tumors, radical nephrectomy is preferred with excision of the affected kidney, lymph nodes, and venous thrombi if present. With metastatic disease, cytoreductive nephrectomy has been shown to prolong survival in carefully selected patients, usually with good performance status and with oligometastasis. The surgical nuances, indication, and motivation for each surgical technique will be discussed in this chapter.
7 schema:editor N869c4387721e47bda3a25ff2cb74097a
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N0e583b802a21437ea39954981c6c9d55
11 schema:keywords advanced disease
12 advanced tumors
13 approach
14 armamentarium
15 carcinoma
16 cell carcinoma
17 chapter
18 components
19 cure
20 cytoreductive nephrectomy
21 disease
22 diverse group
23 durable cure
24 excision
25 good performance status
26 group
27 improvement
28 indications
29 integral component
30 kidney
31 lymph nodes
32 management
33 margin
34 mass
35 metastasis
36 metastatic disease
37 modest improvement
38 motivation
39 negative margins
40 nephrectomy
41 nephron-sparing approach
42 nodes
43 nuances
44 oligometastasis
45 oncologic management
46 patient survival
47 patients
48 performance status
49 presence
50 presence of metastases
51 present
52 presentation
53 prolong survival
54 radical nephrectomy
55 renal cell carcinoma
56 renal masses
57 small renal masses
58 spectra
59 status
60 surgical armamentarium
61 surgical excision
62 surgical nuances
63 surgical technique
64 surgical treatment
65 survival
66 systemic therapy
67 technique
68 therapy
69 thrombus
70 treatment
71 tumors
72 venous thrombi
73 schema:name Surgical Treatment for Renal Cell Carcinoma
74 schema:pagination 221-235
75 schema:productId N2c92960089fa4bfba9eb18a031f4ff13
76 Nb1aff882c8324251b3863bcc4759ec1e
77 schema:publisher N8e0674b28c1740248be36e31fcc25f99
78 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083892464
79 https://doi.org/10.1007/978-4-431-55531-5_8
80 schema:sdDatePublished 2022-10-01T06:58
81 schema:sdLicense https://scigraph.springernature.com/explorer/license/
82 schema:sdPublisher N363f6723bb9b4132b97a250828921d5c
83 schema:url https://doi.org/10.1007/978-4-431-55531-5_8
84 sgo:license sg:explorer/license/
85 sgo:sdDataset chapters
86 rdf:type schema:Chapter
87 N0e583b802a21437ea39954981c6c9d55 schema:isbn 978-4-431-55530-8
88 978-4-431-55531-5
89 schema:name Renal Cell Carcinoma
90 rdf:type schema:Book
91 N2c92960089fa4bfba9eb18a031f4ff13 schema:name dimensions_id
92 schema:value pub.1083892464
93 rdf:type schema:PropertyValue
94 N363f6723bb9b4132b97a250828921d5c schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 N3eb11fad658e479fb4ca85117129bca0 rdf:first sg:person.01040121722.56
97 rdf:rest rdf:nil
98 N60614f787a5748aabb23c18a85871aad rdf:first sg:person.01264361105.40
99 rdf:rest Ne25a3824e69a493db00dcd69ea46af26
100 N869c4387721e47bda3a25ff2cb74097a rdf:first Nbb26b0c6fb14442889005af3c1e16737
101 rdf:rest rdf:nil
102 N8e0674b28c1740248be36e31fcc25f99 schema:name Springer Nature
103 rdf:type schema:Organisation
104 Nb1aff882c8324251b3863bcc4759ec1e schema:name doi
105 schema:value 10.1007/978-4-431-55531-5_8
106 rdf:type schema:PropertyValue
107 Nbb26b0c6fb14442889005af3c1e16737 schema:familyName Oya
108 schema:givenName Mototsugu
109 rdf:type schema:Person
110 Ne25a3824e69a493db00dcd69ea46af26 rdf:first sg:person.01246663563.08
111 rdf:rest N3eb11fad658e479fb4ca85117129bca0
112 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
113 schema:name Medical and Health Sciences
114 rdf:type schema:DefinedTerm
115 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
116 schema:name Oncology and Carcinogenesis
117 rdf:type schema:DefinedTerm
118 sg:person.01040121722.56 schema:affiliation grid-institutes:grid.240145.6
119 schema:familyName Wood
120 schema:givenName Christopher G.
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56
122 rdf:type schema:Person
123 sg:person.01246663563.08 schema:affiliation grid-institutes:grid.240145.6
124 schema:familyName Karam
125 schema:givenName Jose A.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246663563.08
127 rdf:type schema:Person
128 sg:person.01264361105.40 schema:affiliation grid-institutes:grid.240145.6
129 schema:familyName Kim
130 schema:givenName Dae Y.
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264361105.40
132 rdf:type schema:Person
133 grid-institutes:grid.240145.6 schema:alternateName Department of Urology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, 77030, Houston, TX, USA
134 schema:name Department of Urology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, 77030, Houston, TX, USA
135 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...